ChronoScale Corporation Common Stock (NASDAQ:CHRN) Releases Quarterly Earnings Results

ChronoScale Corporation Common Stock (NASDAQ:CHRN) announced its quarterly earnings data on Tuesday. The company reported ($3.89) earnings per share (EPS) for the quarter, FiscalAI reports. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The company had revenue of $18.09 million during the quarter.

ChronoScale Corporation Common Stock Price Performance

Shares of CHRN stock opened at $17.64 on Thursday. ChronoScale Corporation Common Stock has a 12 month low of $2.91 and a 12 month high of $28.20. The company has a market capitalization of $62.85 million, a P/E ratio of -3.28 and a beta of 0.99. The stock has a 50 day moving average of $17.21 and a two-hundred day moving average of $12.03. The company has a current ratio of 1.55, a quick ratio of 1.03 and a debt-to-equity ratio of 0.25.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a report on Friday, March 27th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $6.00.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Consolidated Portfolio Review Corp acquired a new stake in ChronoScale Corporation Common Stock during the third quarter worth $333,000. Citadel Advisors LLC bought a new position in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth about $198,000. Shay Capital LLC acquired a new stake in shares of ChronoScale Corporation Common Stock during the 3rd quarter valued at about $67,000. Virtu Financial LLC acquired a new stake in shares of ChronoScale Corporation Common Stock during the 3rd quarter valued at about $57,000. Finally, Geode Capital Management LLC increased its stake in ChronoScale Corporation Common Stock by 68.9% in the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after acquiring an additional 10,281 shares during the period. 6.42% of the stock is owned by institutional investors.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.